KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Eli Lilly (LLY) over the last 14 years, with Q3 2025 value amounting to $3.3 billion.

  • Eli Lilly's Receivables - Other rose 9066.54% to $3.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 billion, marking a year-over-year increase of 9066.54%. This contributed to the annual value of $2.3 billion for FY2024, which is 106.87% up from last year.
  • Per Eli Lilly's latest filing, its Receivables - Other stood at $3.3 billion for Q3 2025, which was up 9066.54% from $3.0 billion recorded in Q2 2025.
  • Eli Lilly's Receivables - Other's 5-year high stood at $3.3 billion during Q3 2025, with a 5-year trough of $1.1 billion in Q1 2021.
  • Moreover, its 5-year median value for Receivables - Other was $1.7 billion (2022), whereas its average is $1.8 billion.
  • In the last 5 years, Eli Lilly's Receivables - Other crashed by 2002.09% in 2024 and then skyrocketed by 9066.54% in 2025.
  • Over the past 5 years, Eli Lilly's Receivables - Other (Quarter) stood at $1.5 billion in 2021, then grew by 14.34% to $1.7 billion in 2022, then skyrocketed by 35.05% to $2.2 billion in 2023, then grew by 1.07% to $2.3 billion in 2024, then soared by 47.59% to $3.3 billion in 2025.
  • Its Receivables - Other stands at $3.3 billion for Q3 2025, versus $3.0 billion for Q2 2025 and $2.0 billion for Q1 2025.